ArticleBMC infectious diseases2024

Impact of FCGR2A rs1801274 and IL-6R rs2228145 polymorphisms on tocilizumab response in the Iranian population with severe COVID-19.

Nastaran Injinari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.